NCT06141096View on ClinicalTrials.gov

MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2025

Conditions
Safety IssuesEffect of DrugTolerance
Interventions
DRUG

MB07133

Evaluate the effectiveness and safety of different doses of MB07133

Trial Locations (1)

Unknown

RECRUITING

Fifth Medical Center of Chinese PLA General Hospital, Beijing

All Listed Sponsors
collaborator

The First Hospital of Jilin University

OTHER

lead

Xi'an Xintong Pharmaceutical Research Co.,Ltd.

OTHER

NCT06141096 - MB07133 for the Treatment of Patients With Unresectable Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter